Page 1 of Clinical Trials for Drug fluticasone salmeterol Advair, 66 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Atlantis Symbicort
Last Updated: March 26, 2009
Condition(s): Asthma
2
Withdrawn
The Impact of Salmeterol-Fluticasone on Sleep in Patients With COPD
Last Updated: February 29, 2012
Condition(s): Chronic Obstructive Pulmonary Disease; Sleep Disorders
3
Completed
Chronic Obstructive Pulmonary Disease (COPD)-Related Outcomes and Costs for Patients on Combination Fluticasone Propionate-Salmeterol Xinafoate 250/50mcg Versus Anticholinergics in a COPD-Comorbid Depression/Anxiety Population
Last Updated: June 16, 2011
Condition(s): Pulmonary Disease, Chronic Obstructive
4
Completed
Chronic Obstructive Pulmonary Disease (COPD)-Related Healthcare Utilization and Costs After Discharge From a Hospitalization or Emergency Department Visit on a Regimen of Fluticasone Propionate-Salmeterol Combination Versus Other Maintenance Therapies
Last Updated: August 4, 2011
Condition(s): Pulmonary Disease, Chronic Obstructive
5
Completed
Adolescent and Adult Subjects With Asthma and Seasonal Allergic Rhinitis Receiving Advair Diskus or Placebo
Last Updated: March 20, 2008
Condition(s): Asthma; Seasonal Allergic Rhinitis
6
Not yet recruiting
Comparing Fluticasone-Salmeterol in Chronic Obstructive Pulmonary Disease (COPD) and Sleep
Last Updated: August 8, 2008
Condition(s): COPD
7
Recruiting
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
Last Updated: May 10, 2012
Condition(s): Asthma
8
Completed
Effects of Advair® in Outpatients With Chronic Obstructive Pulmonary Disease (COPD) Acute Exacerbation
Last Updated: June 16, 2011
Condition(s): Chronic Obstructive Pulmonary Disease (COPD)
9
Completed
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Last Updated: March 17, 2011
Condition(s): Asthma
10
Recruiting
SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma.
Last Updated: May 10, 2012
Condition(s): Asthma
11
Completed
Pilot Study to Examine the Post-Dose Changes in Exhaled Nitric Oxide (eNO) Following Treatment With Fluticasone Propionate (FP)/Salmeterol (SAL) Combination Product Advair
Last Updated: February 24, 2010
Condition(s): Asthma
12
Completed
Symbicort Onset of Action 1
Last Updated: April 3, 2009
Condition(s): Asthma
13
Completed
Fall Epidemic Viral Pediatric Study
Last Updated: November 17, 2011
Condition(s): Asthma
14
Recruiting
Onset of Action of Advair Hydrofluoroalkane (HFA) 115/21 in Comparison to Symbicort Pressurised Metered-Dose Inhalers (pMDI) 160/4.5 Measured by Impulse Oscillometry (IOS)
Last Updated: March 23, 2009
Condition(s): Asthma
15
Completed
A Study In Pediatric Subjects With Asthma Using ADVAIR HFA, ADVAIR HFA With Spacer, And ADVAIR DISKUS
Last Updated: March 17, 2011
Condition(s): Asthma
16
Completed
Fluticasone Propionate-salmeterol Combination Adherence in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Last Updated: March 15, 2012
Condition(s): Pulmonary Disease, Chronic Obstructive
17
Active, not recruiting
Chronic Obstructive Pulmonary Disease (COPD) Post-hospitalization Study
Last Updated: February 2, 2012
Condition(s): Pulmonary Disease, Chronic Obstructive; Chronic Obstructive Pulmonary Disease
18
Completed
A 24-Week Study to Evaluate the Safety and Efficacy of ADVAIR DISKUS 250/50mcg Plus SPIRIVA HANDIHALER Versus SPIRIVA HANDIHALER Plus Placebo DISKUS in Subjects With Chronic Obstructive Pulmonary Disease (COPD). SPIRIVA and HANDIHALER Are Trade Marks of Boehringer Ingelheim
Last Updated: May 17, 2012
Condition(s): Pulmonary Disease, Chronic Obstructive
19
Recruiting
Can Advair and Flovent Reduce Systemic Inflammation Related to Chronic Obstructive Pulmonary Disease (COPD)? A Multi-Center Randomized Controlled Trial
Last Updated: May 8, 2006
Condition(s): Chronic Obstructive Pulmonary Disease
20
Completed
A 16-Week Study to Evaluate the Effect of Advair DISKUS™ 250/50mcg on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Last Updated: December 16, 2010
Condition(s): CV Risk; Pulmonary Disease, Chronic Obstructive; Chronic Bronchitis; Chronic Obstructive Pulmonary Disease (COPD); Cardiovascular Disease; Smoking; Emphysema

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+fluticasone+salmeterol+Advair

Page 1 of Clinical Trials for Drug fluticasone salmeterol Advair, 66 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About